GENE ONLINE|News &
GLP-1 Medicines Promise More Than Weight Loss—But at What Cost?
“GLP-1 therapies are not just weight-loss drugs—they are systemic treatments reshaping how we think about chronic disease,” Jens Juul Holst. Image: GeneOnline
A new class of medicines is reshaping how we think about obesity, diabetes, and chronic disease. GLP-1 receptor agonists, once confined to diabetes care, are now headline-makers for their striking weight-loss effects. But their impact goes deeper: trials suggest benefits for the heart, kidneys, and even cancer risk. With demand skyrocketing, questions remain about how … GLP-1 Medicines Promise More Than Weight Loss—But at What Cost? Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
